Rockwell Medical (RMTI) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $7.43, -6.89% vs the prior close of $7.98.
- Volume 94.81K shares, 3.6x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
RMTI slides 6.9% to $7.43, a 1-month low on 3.6x normal volume. Closed at $7.43, -6.89% vs the prior close of $7.98. Day range $7.24–$7.97, opened at $7.92.
RMTI daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — RMTI slides 6.9% to $7.43, a 1-month low on 3.6x normal volume
- Closed at $7.43, -6.89% vs the prior close of $7.98. Day range $7.24–$7.97, opened at $7.92.
- Volume was 94.81K shares, 3.6x its 50-day average of 26.66K — unusually heavy trading.
- Price is -6.7% vs its 50-day average ($7.96) and -11.0% vs its 200-day average ($8.35).
- 52-week range $4.89–$12.90; today's close sits at 32% of that range, 42.4% below the 52-week high.
Oct 15, 2026 — RMTI jumps 4.2% to $7.98 on 3.1x normal volume
- Closed at $7.98, +4.18% vs the prior close of $7.66. Day range $7.36–$8.24, opened at $7.76.
- Volume was 79.30K shares, 3.1x its 50-day average of 25.42K — unusually heavy trading.
- Price is +0.3% vs its 50-day average ($7.96) and -4.5% vs its 200-day average ($8.35).
- 52-week range $4.89–$12.90; today's close sits at 39% of that range, 38.1% below the 52-week high.
Oct 14, 2026 — RMTI dips 2.4% to $7.66
- Closed at $7.66, -2.42% vs the prior close of $7.85. Day range $7.66–$7.94, opened at $7.80.
- Volume was 15.60K shares, 0.6x its 50-day average of 25.84K.
- Price is -3.6% vs its 50-day average ($7.94) and -8.3% vs its 200-day average ($8.35).
- 52-week range $4.89–$12.90; today's close sits at 35% of that range, 40.6% below the 52-week high.
Oct 13, 2026 — RMTI jumps 3.7% to $7.85
- Closed at $7.85, +3.70% vs the prior close of $7.57. Day range $7.56–$8.10, opened at $7.71.
- Volume was 30.60K shares, 1.2x its 50-day average of 25.61K.
- Price is -1.2% vs its 50-day average ($7.94) and -6.1% vs its 200-day average ($8.36).
- 52-week range $4.89–$12.90; today's close sits at 37% of that range, 39.1% below the 52-week high.
Oct 12, 2026 — RMTI slides 4.1% to $7.57, a 1-month low on 2.2x normal volume
- Closed at $7.57, -4.06% vs the prior close of $7.89. Day range $7.50–$7.96, opened at $7.86.
- Volume was 54.20K shares, 2.2x its 50-day average of 24.89K — unusually heavy trading.
- Price is -4.5% vs its 50-day average ($7.93) and -9.4% vs its 200-day average ($8.36).
- 52-week range $4.89–$12.90; today's close sits at 33% of that range, 41.3% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — RMTI dips 1.6% to $7.89
- Closed at $7.89, -1.62% vs the prior close of $8.02. Day range $7.89–$8.03, opened at $7.97.
- Volume was 7.90K shares, 0.3x its 50-day average of 24.96K — lighter than usual.
- Price is -0.4% vs its 50-day average ($7.92) and -5.6% vs its 200-day average ($8.36).
- 52-week range $4.89–$12.90; today's close sits at 37% of that range, 38.8% below the 52-week high.
Oct 8, 2026 — RMTI dips 2.4% to $8.02
- Closed at $8.02, -2.43% vs the prior close of $8.22. Day range $8.02–$8.20, opened at $8.08.
- Volume was 8.70K shares, 0.3x its 50-day average of 25.21K — lighter than usual.
- Price is +1.4% vs its 50-day average ($7.91) and -4.1% vs its 200-day average ($8.36).
- 52-week range $4.89–$12.90; today's close sits at 39% of that range, 37.8% below the 52-week high.
Oct 7, 2026 — RMTI jumps 7.5% to $8.22 on 2.1x normal volume
- Closed at $8.22, +7.45% vs the prior close of $7.65. Day range $7.68–$8.31, opened at $7.68.
- Volume was 52.60K shares, 2.1x its 50-day average of 24.70K — unusually heavy trading.
- Price is +4.3% vs its 50-day average ($7.88) and -1.8% vs its 200-day average ($8.37).
- 52-week range $4.89–$12.90; today's close sits at 42% of that range, 36.3% below the 52-week high.
Oct 6, 2026 — RMTI slides 7.0% to $7.65, a 1-month low on 2.7x normal volume
- Closed at $7.65, -7.05% vs the prior close of $8.23. Day range $7.60–$8.24, opened at $8.02.
- Volume was 65.40K shares, 2.7x its 50-day average of 24.67K — unusually heavy trading.
- Price is -2.7% vs its 50-day average ($7.86) and -8.6% vs its 200-day average ($8.37).
- 52-week range $4.89–$12.90; today's close sits at 34% of that range, 40.7% below the 52-week high.
Oct 5, 2026 — RMTI slides 4.9% to $8.23
- Closed at $8.23, -4.86% vs the prior close of $8.65. Day range $8.23–$8.55, opened at $8.50.
- Volume was 10.10K shares, 0.4x its 50-day average of 24.64K — lighter than usual.
- Price is +4.9% vs its 50-day average ($7.85) and -1.7% vs its 200-day average ($8.37).
- 52-week range $4.89–$12.90; today's close sits at 42% of that range, 36.2% below the 52-week high.
Oct 2, 2026 — RMTI rises 0.9% to $8.65
- Closed at $8.65, +0.93% vs the prior close of $8.57. Day range $8.50–$8.73, opened at $8.51.
- Volume was 12.60K shares, 0.5x its 50-day average of 24.73K — lighter than usual.
- Price is +10.7% vs its 50-day average ($7.81) and +3.3% vs its 200-day average ($8.37).
- 52-week range $4.89–$12.90; today's close sits at 47% of that range, 32.9% below the 52-week high.
RMTI latest news & SEC filings
Every SEC filing by or about RMTI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Strobeck Mark sold 1,000 shares at $8.42 (≈$8.42K) on Oct 1, 2026; now holds 61,349
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$1.17M (prior year -$1.49M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.34 (prior year -$0.48) (loss narrowed vs Jun 30, 2025)
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 20, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.03 — Change to shareholder rights.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Things to know before you trade RMTI
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Mar 26, 2026, Jan 20, 2026. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.32% (largest 7.8%). That is a volatile stock.
- Liquidity: about 30.67K shares (≈$227.88K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $7.43 vs a range of $4.89–$12.90 (32% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:10 on Jul 1, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Jesse Neri sold 886 shares on Jan 2, 2026.
- Latest filings: 8-K Aug 13, 2026; 10-Q Aug 13, 2026; 8-K Aug 13, 2026.
- Share count: 4.03M shares outstanding (Aug 10, 2026), -88.3% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
RMTI market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 7.92 | 7.97 | 7.24 | 7.43 | 94.81K |
| Oct 15, 2026 | 7.76 | 8.24 | 7.36 | 7.98 | 79.30K |
| Oct 14, 2026 | 7.80 | 7.94 | 7.66 | 7.66 | 15.60K |
| Oct 13, 2026 | 7.71 | 8.10 | 7.56 | 7.85 | 30.60K |
| Oct 12, 2026 | 7.86 | 7.96 | 7.50 | 7.57 | 54.20K |
| Oct 9, 2026 | 7.97 | 8.03 | 7.89 | 7.89 | 7.90K |
| Oct 8, 2026 | 8.08 | 8.20 | 8.02 | 8.02 | 8.70K |
| Oct 7, 2026 | 7.68 | 8.31 | 7.68 | 8.22 | 52.60K |
| Oct 6, 2026 | 8.02 | 8.24 | 7.60 | 7.65 | 65.40K |
| Oct 5, 2026 | 8.50 | 8.55 | 8.23 | 8.23 | 10.10K |
| Oct 2, 2026 | 8.51 | 8.73 | 8.50 | 8.65 | 12.60K |
| Oct 1, 2026 | 8.42 | 8.74 | 8.42 | 8.57 | 11.10K |
| Sep 30, 2026 | 8.74 | 8.74 | 8.29 | 8.54 | 21.30K |
| Sep 29, 2026 | 8.60 | 8.73 | 8.53 | 8.68 | 13.00K |
| Sep 28, 2026 | 8.54 | 8.74 | 8.26 | 8.63 | 17.60K |
| Sep 25, 2026 | 8.42 | 8.56 | 8.35 | 8.37 | 6.40K |
| Sep 24, 2026 | 8.59 | 8.70 | 7.91 | 8.57 | 15.80K |
| Sep 23, 2026 | 8.26 | 8.83 | 8.26 | 8.57 | 9.50K |
| Sep 22, 2026 | 8.74 | 8.88 | 8.46 | 8.86 | 27.20K |
| Sep 21, 2026 | 8.15 | 8.90 | 8.06 | 8.70 | 59.70K |
About Rockwell Medical
Rockwell Medical (RMTI) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in WIXOM, MI. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1041024.
RMTI board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| John G Cooper | Director | Jul 6, 2026 |
| Joseph H Dawson | Director | Jul 6, 2026 |
| Joan Lau | Director | Jul 6, 2026 |
| Allen Nissenson | Director | Jul 6, 2026 |
| Robert S Radie | Director | Jul 6, 2026 |
| Mark Strobeck | President and CEO | Jul 6, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Timothy Chole | SVP and CCO | Jul 6, 2026 |
| Heather Hunter | Chief Operating Officer | Jul 6, 2026 |
| Jesse Neri | SVP and CFO | Jul 6, 2026 |
| Mark Strobeck | President and CEO | Jul 6, 2026 |
| Megan C. Timmins | EVP, CLO & Secretary | Jul 6, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jan 2, 2026 | Jesse Neri | Sale | 886 | $0.84 |
| Jan 2, 2026 | Jesse Neri | Sale | 886 | $0.84 |
| Jan 2, 2026 | Jesse Neri | Sale | 886 | $0.84 |
| Jan 2, 2026 | Jesse Neri | Sale | 886 | $0.84 |
| Jan 2, 2026 | Heather Hunter | Sale | 2,868 | $0.84 |
| Jan 2, 2026 | Heather Hunter | Sale | 2,868 | $0.84 |
| Jan 2, 2026 | Heather Hunter | Sale | 2,868 | $0.84 |
| Jan 2, 2026 | Heather Hunter | Sale | 2,868 | $0.84 |
| Nov 18, 2025 | John G Cooper | Sale | 5,079 | $0.87 |
| Nov 18, 2025 | John G Cooper | Sale | 5,079 | $0.87 |
| Nov 18, 2025 | John G Cooper | Sale | 5,079 | $0.87 |
| Nov 18, 2025 | John G Cooper | Sale | 5,079 | $0.87 |
| Oct 1, 2025 | Heather Hunter | Sale | 2,868 | $1.19 |
| Oct 1, 2025 | Heather Hunter | Sale | 2,868 | $1.19 |
| Oct 1, 2025 | Heather Hunter | Sale | 2,868 | $1.19 |
RMTI financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-5.31M | -0.15 | $-659.00K |
| Dec 31, 2024 | — | $-480.00K | -0.03 | $4.20M |
| Dec 31, 2023 | — | $-8.44M | -0.37 | $-9.41M |
| Dec 31, 2022 | — | $-18.68M | -1.31 | $-16.93M |
| Dec 31, 2021 | — | $-32.67M | -3.83 | $-33.53M |
Latest balance sheet: total assets $56.53M, total liabilities $21.44M, cash $10.52M (as of Jun 30, 2026).
RMTI earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $7.83 |
| May 7, 2026 | 8-K Item 2.02 (results) | $7.80 |
| Mar 26, 2026 | 8-K Item 2.02 (results) | $9.40 |
| Jan 20, 2026 | 8-K Item 2.02 (results) | $12.60 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $9.60 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $10.50 |
| May 12, 2025 | 8-K Item 2.02 (results) | $10.40 |
| Mar 20, 2025 | 8-K Item 2.02 (results) | $14.00 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $28.30 |
| May 14, 2024 | 8-K Item 2.02 (results) | — |
| Mar 21, 2024 | 8-K Item 2.02 (results) | — |
| Jan 8, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on RMTI
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.